AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Bittium Oyj

Director's Dealing Sep 17, 2020

3258_dirs_2020-09-17_54211711-09dc-47a8-b985-b29b284a922d.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

Bittium Corporation: Notification of Manager's Transactions

Stock Exchange Release

Free for publication on September 17, 2020 at 3.45 p.m. (CEST+1)

Bittium Corporation: Notification of Manager's Transactions

Personsubject tothe notificationrequirement

Name: Jari-Pekka Innanen Position:Other senior manager

Notification type: Initial Notification Reference number: 743700NFG5W5I59OVX65_20200916122910_2

Issuer: Bittium Corporation LEI: 743700NFG5W5I59OVX65

Transactiondate:September 15, 2020

Venue: BATE Instrument: Share ISIN: FI0009007264 Nature of transaction: Disposal

Transactiondetails

  1. Volume: 15, unit price: 7.05000 EUR

Aggregatedtransactions

Volume: 15 Volume weighted average price: 7.05000 EUR

Transactiondate:September 16, 2020 Venue: XHEL Instrument: Share

ISIN: FI0009007264 Nature of transaction: Disposal

  1. Volume: 985, unit price: 7.13000 EUR

Aggregatedtransactions

Volume: 985 Volume weighted average price: 7.13000 EUR

Oulu, September 17, 2020

Hannu Huttunen CEO

Further information:

Kari Jokela Chief Legal Officer Tel. +358 40 344 5258

Distribution

Nasdaq Helsinki Oy Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivitysolutions leveraging its 35 year legacyof expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&Dservices. Complementing its communications and connectivitysolutions, Bittium offers proven information securitysolutions for mobile devices and portable computers. Bittium also provides healthcare technologyproducts and services for biosignal measuring in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2019 were EUR75.2 million and operating profitwas EUR6.3 million. Bittium is listed on Nasdaq Helsinki.www.bittium.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.